HIV Integrase Inhibitor - Selected Scientific Papers
Leh H, Thomas C-M, Zouhiri F, Chéret A and Mouscadet J-F. Styrylquinolines Derivatives Targeting HIV Integrase are in vitro Synergic with Reverse Transcriptase Inhibitors and Diketo Acids. Poster Presentation. 12th Conference on Retroviruses and Opportunistic Infections (CROI), Boston February 2005. View Poster.
Firley D, Fraisse B, Zouhiri F, Spasojevic-de Bire A, Desmaele
D, d'Angelo J, Ghermani NE. 7-Carboxylato-8-hydroxy-2-methylquinolinium
monohydrate and 7-carboxy-8-hydroxy-2-methylquinolinium chloride
monohydrate at 100 K. Acta Crystallogr C. 2005 Mar;61(Pt 3):
o154-7. View Abstract on PubMed
Mousnier A, Leh H, Mouscadet JF, Dargemont C. Nuclear import
of HIV-1 integrase is inhibited in vitro by styrylquinoline
derivatives. Mol Pharmacol . 2004 Oct; 66(4): 783-8.
Epub 2004 Jul 09. View
Abstract on PubMed.
Bonnenfant S, Thomas CM, Vita C, Subra F, Deprez E, Zouhiri F, Desmaele D, D'Angelo J, Mouscadet JF, Leh H. Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents. J Virol . 2004 Jun; 78(11): 5728-36. View Abstract on PubMed.
Deprez E, Barbe S, Kolaski M, Leh H, Zouhiri F, Auclair C, Brochon JC, Le Bret M, Mouscadet JF. Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. Mol Pharmacol . 2004 Jan; 65(1): 85-98. View Abstract on PubMed.
|
